Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

PRIDE syndrome helps identify skin side effects from EGFR inhibitors like erlotinib.

Preventive measures and effective management are crucial for reducing skin side effects in cancer treatment.

Patients and oncologists prioritize survival benefits, while payers focus on treatment costs.

Ritlecitinib and baricitinib are effective for alopecia areata, but more research is needed to determine which is better.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

Patients with Bohring-Opitz syndrome and ASXL1 mutations need regular kidney ultrasounds to check for tumors.

Tavaborole is a safe and effective toenail fungus treatment, with the 5% solution being the best option.

Topical ruxolitinib failed to regrow hair in a 66-year-old with alopecia areata.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

Some natural compounds may help overcome drug resistance in certain cancers, but more research is needed.

B-Raf and C-Raf are essential for maintaining melanocyte stem cells to prevent hair graying.

S-1 treatment led to a complete response in pancreatic cancer with manageable side effects.

The nanoparticles show promise for cancer treatment and diagnosis with fewer side effects.

Upadacitinib cleared scalp alopecia areata in three patients and also improved atopic dermatitis with minimal side effects.

Bicalutamide improves hair density in women safely.

Adding celecoxib to chemotherapy improves survival and quality of life for gastric cancer patients with positive COX-2.

Genotyping for NUDT15 p.Arg139Cys can help predict thiopurine side effects in Japanese IBD patients.

New cancer treatments show promise in reducing tumor growth and improving skin regeneration in mice.

Baricitinib effectively promotes hair regrowth in severe alopecia with minimal side effects.

Secukinumab treatment may cause HBV reactivation and hair discoloration.

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.

ADCs can effectively treat breast cancer but may cause side effects like nausea and hair loss.

Caffeine reduces radiation skin damage but doesn't affect tumor treatment.

A balanced approach using dutasteride and Serenoa repens can improve hair transplant success by protecting follicles and minimizing side effects.

Patients with metastatic breast cancer treated with epirubicin and docetaxel had a good response and maintained their quality of life.

Upadacitinib effectively treats psoriasis and lichen planus together.

JAK inhibitors are more effective and safer for treating alopecia areata than dupilumab and apremilast.